No serious side effects have been observed among the vaccine receivers, Gao Xiaojun, a spokesperson for the municipal health commission, as saying at a press briefing on Sunday.
The inoculation, which began on January 1 across 220 venues in Beijing, currently mainly covers nine groups of people aged 18 to 59 in Beijing.
These include frontline customs inspectors of imported cold-chain goods and personnel working in the overseas and domestic transportation sector.
People receiving the jab will have the information updated on Beijing's health code app, Gao said, adding that those who have urgent plans to travel overseas can apply for Covid-19 inoculation at the community service centre.
After the vaccines receive market approval, authorities in Beijing will start vaccination for other groups on a reservation basis, said Gao at an earlier press conference.
On December 31, 2020,
The inactivated vaccine got approval from the
It was developed by the Beijing Biological Products Institute Co. Ltd. under the
SEE ALSO:
Top stocks to watch — BEML, HCL Tech, Infosys, Tech Mahindra, TCS, RIL, Tata Motors Hero Moto, TVS, and others
Upcoming new cars in India in 2021 of Maruti, Tata, MG, Audi
Where is Jack Ma? Questions arise about the billionaire’s whereabouts as Alibaba faces scrutiny from the Chinese government